2006 Press Releases

• Tranzyme Pharma Announces Issuance of European Patent Protecting Company's Novel Macrocyclic Chemistry

  December 13, 2006

• Tranzyme Pharma Expands Clinical Program of its Novel Ghrelin Agonist, TZP-101, to Include Patients with Gastroparesis

  September 21, 2006

• Tranzyme Pharma Appoints New Vice President of Business Development & Licensing

  August 10, 2006

• Tranzyme Pharma Receives Notice of Allowance from USPTO on Patent Protecting Company’s Macrocyclic Chemistry Technology

  July 19, 2006

• Tranzyme Pharma Appoints Industry Veteran as Senior Vice President of Research and Preclinical Development

  June 21, 2006

• Tranzyme Pharma to Present New In Vivo Data on its Novel GI Compounds at Digestive Disease Week 2006

  May 17, 2006

• Tranzyme Pharma Announces Successful Completion of Phase I Clinical Trial of its Novel Ghrelin Agonist, TZP-101

  May 10, 2006

• Tranzyme Pharma Receives IND Clearance for its Novel Ghrelin Agonist, TZP-101

  January 10, 2006

Archives

• 2009 Press Releases
• 2008 Press Releases
• 2007 Press Releases
• 2006 Press Releases
• 2005 Press Releases
• 2004 Press Releases
• 2003 Press Releases